THE ROLE OF CXCL4, CXCL8 AND GDF-15 IN SYSTEMIC SCLEROSIS

被引：0

作者：

Oller Rodriguez, J. E. ^{[1
]}

Grau Garcia, E. ^{[1
]}

Gonzalez Mazario, R. ^{[1
]}

De la Rubia Navarro, M. ^{[1
]}

Pavez Perales, C. ^{[1
]}

Leal Rodriguez, S. ^{[1
]}

Martinez Cordellat, I. ^{[1
]}

Ortiz Sanjuan, F. M. ^{[1
]}

Vicens Bernabeu, E. ^{[1
]}

Negueroles Albuixech, R. ^{[1
]}

Chalmeta Verdejo, I. ^{[1
]}

Alcaniz Escandell, C. ^{[1
]}

Fragio-Gil, J. J. ^{[1
]}

Canovas Olmos, I. ^{[1
]}

Najera Herranz, C. ^{[1
]}

Gonzalez Puig, L. ^{[1
]}

Ivorra Cortes, J. ^{[1
]}

Hervas Marin, D. ^{[2
]}

Roman Ivorra, J. A. ^{[1
]}

机构：

[1] Rheumatol Serv HUP La Fe, Valencia, Spain

[2] Biostat Unit IIS La Fe, Valencia, Spain

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.5019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0165

引用

页码：1378 / 1379

页数：2

共 50 条

[1] Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis
Oller-Rodriguez, Jose E.
Vicens Bernabeu, Elvira
Gonzalez-Mazario, Roxana
Grau Garcia, Elena
Ortiz Sanjuan, Francisco M.
Roman Ivorra, Jose A.
MEDICINA CLINICA, 2022, 159 (08): : 359 - 365
[2] Plasma CXCL4 As a Biomarker in Juvenile Systemic Sclerosis
Moore, Katharine
Fritzler, Marvin J.
Klein-Gitelman, Marisa S.
Reed, Ann M.
Lee, Tzielan
Stevens, Anne
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[3] Proteome-wide Analysis and CXCL4 in Systemic Sclerosis
George, Peter M.
Wort, S. John
Mitchell, Jane A.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16): : 1561 - 1562
[4] CXCL4: A new biomarker of diagnosis and severity in systemic sclerosis?
Marie, I.
REVUE DE MEDECINE INTERNE, 2015, 36 (02): : 69 - 72
[5] Proteome-wide Analysis and CXCL4 in Systemic Sclerosis REPLY
van Roon, Joel A. G.
Tesselaar, Kiki
Radstake, Timothy R. D. J.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16): : 1563 - 1564
[6] Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
van Bon, L.
Affandi, A. J.
Broen, J.
Christmann, R. B.
Marijnissen, R. J.
Stawski, L.
Farina, G. A.
Stifano, G.
Mathes, A. L.
Cossu, M.
York, M.
Collins, C.
Wenink, M.
Huijbens, R.
Hesselstrand, R.
Saxne, T.
DiMarzio, M.
Wuttge, D.
Agarwal, S. K.
Reveille, J. D.
Assassi, S.
Mayes, M.
Deng, Y.
Drenth, J. P. H.
de Graaf, J.
den Heijer, M.
Kallenberg, C. G. M.
Bijl, M.
Loof, A.
van den Berg, W. B.
Joosten, L. A. B.
Smith, V.
de Keyser, F.
Scorza, R.
Lunardi, C.
van Riel, P. L. C. M.
Vonk, M.
van Heerde, W.
Meller, S.
Homey, B.
Beretta, L.
Roest, M.
Trojanowska, M.
Lafyatis, R.
Radstake, T. R. D. J.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (05): : 433 - 443
[7] DISEASE MODIFYING EFFECT OF ILOPROST IN PATIENTS WITH SYSTEMIC SCLEROSIS AND POSSIBLE ROLE OF CXCL4 CHEMOKINE
Stefanantoni, K.
Sciarra, I.
Vasile, M.
Palazzo, R.
Frasca, L.
Valesini, G.
Riccieri, V.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 903 - 903
[8] CXCL4, CXCL4-DNA/RNA complexes and anti-CXCL4 antibodies are modulated in Systemic Sclerosis patients under Iloprost therapy
Ocone, Giuseppe
Lande, Roberto
Mennella, Anna
Stefanantoni, Katia
Palazzo, Raffaella
Pietraforte, Immacolata
Sciarra, Iliana
Vasile, Massimiliano
Riccieri, Valeria
Frasca, Loredana
EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 906 - 906
[9] Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis
Jiang, Zhixing
Chen, Chen
Yang, Sen
He, Hang
Zhu, Xiaoxia
Liang, Minrui
JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 104 (01) : 63 - 73
[10] CXCL4 and CXCL4L1 in cancer
Ruytinx, Pieter
Proost, Paul
Struyf, Sofie
CYTOKINE, 2018, 109 : 65 - 71

← 1 2 3 4 5 →